Claritev (NYSE:CTEV - Get Free Report) major shareholder Ares Management Llc bought 13,587 shares of the firm's stock in a transaction that occurred on Wednesday, November 11th. The shares were acquired at an average price of $28.73 per share, with a total value of $390,354.51. Following the acquisition, the insider owned 2,063,105 shares of the company's stock, valued at $59,273,006.65. This represents a 0.66% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.
Ares Management Llc also recently made the following trade(s):
- On Tuesday, November 10th, Ares Management Llc purchased 65,579 shares of Claritev stock. The stock was acquired at an average cost of $26.14 per share, with a total value of $1,714,235.06.
- On Monday, November 9th, Ares Management Llc purchased 50,000 shares of Claritev stock. The stock was bought at an average price of $24.42 per share, for a total transaction of $1,221,000.00.
- On Monday, October 26th, Ares Management Llc acquired 20,834 shares of Claritev stock. The shares were bought at an average cost of $24.07 per share, for a total transaction of $501,474.38.
- On Friday, October 23rd, Ares Management Llc acquired 50,000 shares of Claritev stock. The shares were bought at an average cost of $23.53 per share, for a total transaction of $1,176,500.00.
Claritev Trading Down 6.7%
Shares of NYSE CTEV opened at $25.02 on Tuesday. The firm has a fifty day simple moving average of $25.92 and a two-hundred day simple moving average of $25.45. Claritev has a 12 month low of $11.50 and a 12 month high of $55.50. The firm has a market capitalization of $424.09 million, a PE ratio of -1.52 and a beta of 1.05.
Claritev (NYSE:CTEV - Get Free Report) last announced its earnings results on Monday, November 9th. The company reported $1.77 earnings per share for the quarter, beating analysts' consensus estimates of ($3.68) by $5.45. The company had revenue of $268.31 million for the quarter. On average, sell-side analysts predict that Claritev will post -15.02 earnings per share for the current year.
Wall Street Analyst Weigh In
CTEV has been the topic of several research reports. Wall Street Zen raised Claritev from a "sell" rating to a "hold" rating in a research report on Saturday, August 8th. Zacks Research upgraded Claritev from a "strong sell" rating to a "hold" rating in a report on Thursday, August 13th. Piper Sandler reissued an "overweight" rating and issued a $73.00 target price on shares of Claritev in a research report on Wednesday, August 12th. Weiss Ratings restated a "sell (d-)" rating on shares of Claritev in a research note on Monday, September 21st. Finally, Citigroup restated a "buy" rating and set a $45.00 price target (up from $40.00) on shares of Claritev in a research report on Monday, August 10th. Six investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $44.83.
Read Our Latest Stock Analysis on CTEV
Institutional Trading of Claritev
A number of hedge funds and other institutional investors have recently modified their holdings of CTEV. Goldman Sachs Group Inc. increased its stake in shares of Claritev by 306.7% in the 3rd quarter. Goldman Sachs Group Inc. now owns 109,901 shares of the company's stock worth $2,327,000 after acquiring an additional 82,877 shares in the last quarter. Entropy Technologies LP bought a new stake in Claritev during the third quarter worth about $265,000. Marshall Wace LLP boosted its stake in Claritev by 1,569.2% during the third quarter. Marshall Wace LLP now owns 225,890 shares of the company's stock worth $4,782,000 after acquiring an additional 212,357 shares in the last quarter. Engineers Gate Manager LP bought a new stake in Claritev during the second quarter worth about $245,000. Finally, Integrated Wealth Concepts LLC purchased a new stake in Claritev in the second quarter worth about $44,000. 87.15% of the stock is owned by hedge funds and other institutional investors.
Claritev Company Profile
(
Get Free Report)
Claritev, formerly known as MultiPlan, provides technology-enabled services intended to help manage healthcare costs and support payment accuracy. Its offerings include access to provider networks, claims and payment solutions, and data analytics for evaluating healthcare costs and utilization. The company serves health plans, self-insured employers, third-party administrators and other participants in the U.S. healthcare system. Its services are designed to help customers identify cost-management opportunities and support more efficient healthcare transactions.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].